General Anesthetic Binding Sites in Human α4β3δ γ-Aminobutyric Acid Type A Receptors (GABAARs).

Extrasynaptic γ-aminobutyric acid type A receptors (GABAA Rs),which contribute generalized inhibitory tone to the mammalian brain, are major targets for general anesthetics. To identify anesthetic binding sites in an extrasynaptic GABAA R, we photolabeled human α4β3δ GABAA Rs purified in detergent with [3 H]azietomidate and a barbiturate, [3 H]R-mTFD-MPAB, photoreactive anesthetics that bind with high selectivity to distinct but homologous intersubunit binding sites in the transmembrane domain of synaptic α1β3γ2 GABAA Rs. Based upon3 H incorporation into receptor subunits resolved by SDS-PAGE, there was etomidate-inhibitable labeling by [3 H]azietomidate in the α4 and β3 subunits and barbiturate-inhibitable labeling by [3 H]R-mTFD-MPAB in the β3 subunit. These sites did not bind the anesthetic steroid alphaxalone, which enhanced photolabeling, or DS-2, a δ subunit-selective positive allosteric modulator, which neither enhanced nor inhibited photolabeling. The amino acids labeled by [3 H]azietomidate or [3 H]R-mTFD-MPAB were identified by N-terminal sequencing of fragments isolated by HPLC fractionation of enzymatically digested subunits. No evidence was found for a δ subunit contribution to an anesthetic binding site. [3 H]azietomidate photolabeling of β3Met-286 in βM3 and α4Met-269 in αM1 that was inhibited by etomidate but not by R-mTFD-MPAB established that etomidate binds to a site at the β3+ -α4- interface equivalent to its site in α1β3γ2 GABAA Rs. [3 H]Azietomidate and [3 H]R-mTFD-MPAB photolabeling of β3Met-227 in βM1 established that these anesthetics also bind to a homologous site, most likely at the β3+ -β3- interface, which suggests a subunit arrangement of β3α4β3δβ3.